Cognixion’s breakthrough approval gives them “a tremendous advantage”

Santa Barbara-based Cognixion has received a Breakthrough Device designation from the U.S. FDA, paving the way to get its artificial intelligence-powered neural interface to the market faster.

Read Full Article